Bristol Myers Squibb published the 2026 W36 TidyTuesday report and the Cappuccino Index.
Public source
Publisher name
Public post
📊 #TidyTuesday – 2026 W36 | The Cappuccino Index . 🔗: https://lnkd.in/gjsHrDBN . #rstats | #r4ds | #dataviz | #ggplot2
Company
Bristol Myers Squibb
- Industry
- Pharmaceutical Manufacturing
- Location
- Lawrence Township, US
- Company size
- 10,001+ employees
About Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
See moreLatest activity
Latest activity from Bristol Myers Squibb
51 signals
Presence & Recognition
Bristol Myers Squibb France team will depart for the 11th edition of Country 2 Country 4 Cancer from 16 to 18 September.
Research & Knowledge
Bristol Myers Squibb announced positive topline results from a registrational Phase 2 trial evaluating an investigational CAR T cell therapy in certain patients with relapsed or refractory multiple myeloma.
People
Bristol Myers Squibb General Manager Spain & Portugal Sandra Orta accepted her new role in BMS in the United States.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Pfizer
Pfizer reported that 75.5% of U.S. healthcare professionals say AI training is unavailable, limited, or inconsistent according to the Philips Future Health Index 2026.
Research & Knowledge
Takeda
Takeda published a paper titled V-SYNTHES2 introducing a next-generation approach for structure-based virtual screening across giga-scale chemical spaces.
Research & Knowledge
Zambon
Zambon published its new Value Report online, reflecting on the company's progress, innovation, and commitment to creating sustainable value for patients, communities, and future generations.
Research & Knowledge
Novo Nordisk
Novo Nordisk is building the biggest cardiometabolic clinical trial data foundation in the world, with over 200,000 patient-years of data and counting.
Research & Knowledge
AstraZeneca